Evaluation of the Efficacy of Tocilizumab in Cytokine Release Syndrome in Patients with COVID-19 (SARS-CoV-2) Pneumonia Followed in the Intensive Care Unit

Objective: The global severe acute respiratory syndrome-coronavirus-2 pandemic, which emerged in 2019, has resulted in severe complications in approximately 5% of infected individuals, leading to mortality due to respiratory failure, shock, or multiple organ dysfunction. Mortality is primarily attri...

Full description

Bibliographic Details
Published in:Bagcilar Medical Bulletin
Main Authors: Serpil Şehirlioğlu, Fatma Özdemir, Melike Tezdönen, Ülkü Aygen Türkmen, Döndü Genç Moralar
Format: Article
Language:English
Published: Istanbul Bagcilar Training and Research Hospital 2025-09-01
Subjects:
covid-19 pneumonia
cytokine release syndrome
cytokine storm
sars-cov-2
tocilizumab
Online Access:https://www.behmedicalbulletin.org/articles/evaluation-of-the-efficacy-of-tocilizumab-in-cytokine-release-syndrome-in-patients-with-covid-19-sars-cov-2-pneumonia-followed-in-the-intensive-care-unit/doi/BMB.galenos.2025.92400

Internet

https://www.behmedicalbulletin.org/articles/evaluation-of-the-efficacy-of-tocilizumab-in-cytokine-release-syndrome-in-patients-with-covid-19-sars-cov-2-pneumonia-followed-in-the-intensive-care-unit/doi/BMB.galenos.2025.92400

Similar Items